Literature DB >> 9770449

Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.

W S Caughey1, L D Raymond, M Horiuchi, B Caughey.   

Abstract

A central aspect of pathogenesis in the transmissible spongiform encephalopathies or prion diseases is the conversion of normal protease-sensitive prion protein (PrP-sen) to the abnormal protease-resistant form, PrP-res. Here we identify porphyrins and phthalocyanines as inhibitors of PrP-res accumulation. The most potent of these tetrapyrroles had IC50 values of 0.5-1 microM in scrapie-infected mouse neuroblastoma (ScNB) cell cultures. Inhibition was observed without effects on protein biosynthesis in general or PrP-sen biosynthesis in particular. Tetrapyrroles also inhibited PrP-res formation in a cell-free reaction composed predominantly of hamster PrP-res and PrP-sen. Inhibitors were found among phthalocyanines, deuteroporphyrins IX, and meso-substituted porphines; examples included compounds containing anionic, neutral protic, and cationic peripheral substituents and various metals. We conclude that certain tetrapyrroles specifically inhibit the conversion of PrP-sen to PrP-res without apparent cytotoxic effects. The inhibition observed in the cell-free conversion reaction suggests that the mechanism involved direct interactions of the tetrapyrrole with PrP-res and/or PrP-sen. These findings introduce a new class of inhibitors of PrP-res formation that represents a potential source of therapeutic agents for transmissible spongiform encephalopathies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770449      PMCID: PMC22794          DOI: 10.1073/pnas.95.21.12117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain.

Authors:  D A Kocisko; P T Lansbury; B Caughey
Journal:  Biochemistry       Date:  1996-10-15       Impact factor: 3.162

2.  Pi-interactions in metalloporphyrins and hemeproteins.

Authors:  W S Caughey; H Eberspaecher; W H Fuchsman; S McCoy; J O Alben
Journal:  Ann N Y Acad Sci       Date:  1969-01-27       Impact factor: 5.691

3.  Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.

Authors:  A Bossers; G J Raymond; B Caughey; R de Vries; M A Smits
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  The interaction of human serum albumin and hemopexin with porphyrins.

Authors:  W T Morgan; A Smith; P Koskelo
Journal:  Biochim Biophys Acta       Date:  1980-07-24

5.  Potent inhibition of scrapie-associated PrP accumulation by congo red.

Authors:  B Caughey; R E Race
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

6.  Tin-protoporphyrin-mediated disruption in vivo of heme oxygenase-2 protein integrity and activity in rat brain.

Authors:  J A Mark; M D Maines
Journal:  Pediatr Res       Date:  1992-09       Impact factor: 3.756

7.  Aluminium phthalocyanine mediated photodynamic therapy in experimental malignant glioma.

Authors:  S Stylli; J Hill; W Sawyer; A Kaye
Journal:  J Clin Neurosci       Date:  1995-04       Impact factor: 1.961

8.  Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection.

Authors:  C F Farquhar; A G Dickinson
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

9.  Non-genetic propagation of strain-specific properties of scrapie prion protein.

Authors:  R A Bessen; D A Kocisko; G J Raymond; S Nandan; P T Lansbury; B Caughey
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

10.  Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin.

Authors:  O Bing; L Grundemar; L Ny; C Möller; M Heilig
Journal:  Neuroreport       Date:  1995-07-10       Impact factor: 1.837

View more
  52 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

3.  Inhibition of protease-resistant prion protein accumulation in vitro by curcumin.

Authors:  Byron Caughey; Lynne D Raymond; Gregory J Raymond; Laura Maxson; Jay Silveira; Gerald S Baron
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 4.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

Authors:  Carole Crozet; Yea-Lih Lin; Clément Mettling; Chantal Mourton-Gilles; Pierre Corbeau; Sylvain Lehmann; Véronique Perrier
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

6.  Enhanced antiscrapie effect using combination drug treatment.

Authors:  David A Kocisko; Byron Caughey; John D Morrey; Richard E Race
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  De novo designed cyclic-peptide heme complexes.

Authors:  Michael M Rosenblatt; Jiangyun Wang; Kenneth S Suslick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

9.  meso-Tetra(pentafluorophenyl)porphyrin as an efficient platform for combinatorial synthesis and the selection of new photodynamic therapeutics using a cancer cell line.

Authors:  Diana Samaroo; Mikki Vinodu; Xin Chen; Charles Michael Drain
Journal:  J Comb Chem       Date:  2007-09-15

10.  Poly-L-histidine inhibits prion propagation in a prion-infected cell line.

Authors:  Ryo Honda; Kei-Ichi Yamaguchi; Abdelazim Elsayed Elhelaly; Mitsuhiko Fuji; Kazuo Kuwata
Journal:  Prion       Date:  2018-08-17       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.